Reply to the Comment on: “Prediction of Diabetes Remission in Morbidly Obese Patients After Roux-en-Y Gastric Bypass”
- 123 Downloads
Reply to a Letter to the Editor:
A Letter to the Editor regarding our previous study entitled “Prediction of diabetes remission in morbidly obese patients after Roux-en-Y gastric bypass” was submitted by an anonymous author, possibly from a Taiwanese study group as revealed from the context of the letter . We appreciate the author’s interest and comments regarding our results.
Since the author suggested the idea of validating the efficacy of the ABCD score and the DiaRem score with our own study cohort, we would like to describe the data for these two preoperative scoring systems to evaluate the predictability of diabetes remission in our cohort.
As described in our original publication, we defined complete remission and partial remission as an HbA1c level of <6.0 and <6.5 % without any antidiabetic medications, respectively. The scoring systems were adopted from the previously published studies by Still CD et al. (the DiaRem score) and Lee WJ et al. (the modified ABCD score) [2, 3]...
KeywordsMetformin Gastric Bypass HbA1c Level Score Group Antidiabetic Medication
Min Ju Soh, a research coordinator, contributed to this manuscript by collecting data for the analyses.
Compliance with ethical standards
Conflict of Interest
The authors declare that they have no conflict of interest.
For this type of retrospective study, formal consent is not required.
This does not apply to this retrospective study.